论文部分内容阅读
Anaplastic lymphoma kinase(ALK)is a receptor tyrosine kinase(RTK)belonging to the insulin receptor superfamily.
Design and synthesis of novel 2-aryl-3-benzyloxy-5-chloro-pyrimidine derivatives as anaplastic lymph
【摘 要】
：
Anaplastic lymphoma kinase(ALK)is a receptor tyrosine kinase(RTK)belonging to the insulin receptor superfamily.
【机 构】
：
School of Biological Science & Medical Engineering,Southeast University,Nanjing 210096,China
【出 处】
：
全国药物化学学术会议暨第四届中英药物化学学术会议
【发表日期】
：
2013年11期
其他文献
Title-Improvement of pharmacokinetics behavior of apocynin by nitrone derivatization:Comparative pha
Apocynin,a potent inhibitor of NADPH-oxidase,was widely studied for activities in diseases such as inflammation-mediated disorders,asthma and cardiovascular diseases.
Near-infrared fluorescent dyes have widely used as fluorescence probes,due to their maximum absorption peak is greater than 700nm where a biological matrix exhibits the least absorption and autofluore
The Ras/Raf/MEK/ERK pathway(ERK pathway)is a member of the four distinct mitogen-activated protein kinase(MAPK)signaling pathways,which play critical roles in regulation of diverse cellular activities
会议
Synthesis,biological evaluation,docking and dynamicsstudies of furan-based peptides as 20S proteasom
会议
Design,synthesis and biological evaluation of 1-phenylpyridin-4-one derivatives as potential multita
会议
Atropisomerism of pharmaceutical compounds is a challenging area for drug discovery programs [1].Recently,in our laboratory work,maleopimaric N-naphthylimide was found exhibited anti-proliferative act
DNA拓扑异构酶Ⅰ(Top1)是细胞生存的必需酶，参与DNA 复制、转录、重组、修复的全过程；而且多种肿瘤细胞中尤其是肺癌、胃癌、结肠癌、卵巢癌等Top1的含量明显高于正常细胞。
Design,synthesis and biological activity of 1,2-benzothiazine derivatives as potential anticancer ag
1,2-benzothiazine derivatives as novel potent anticancer drugs atracted great attention.Several authors have reported their inhibitory effects on colorectal cancer,non-small-cell lung cancer,and osteo
Design synthesis and anti-tumor activities of novel salicylamide derivatives as potential anti-tumor
In recent years,the development of EGFR inhibitors focuses on ATP competitive inhibitors,and many small molecules including Gefitinib,Erlotinib and Canertinib etc were approve.